Latest Automation News

Chrysos Corporation reported a robust FY25 with 46% revenue growth and an 80% jump in EBITDA, driven by expanding adoption of its PhotonAssay technology and a landmark contract with gold giant Newmont. The company projects further growth in FY26 with revenue guidance of $80-90 million.

Centrepoint Alliance has reported a robust FY25 with 13% revenue growth and a 30% increase in profit before tax, driven by organic adviser expansion, strategic acquisitions, and pioneering technology investments including AI and cybersecurity.

Helloworld Travel Limited reported a 4.1% rise in profit after tax for FY25 despite an 8.6% decline in total transaction value, underpinned by strong forward bookings and ongoing technology investments.

Helloworld Travel reported a 4.1% rise in profit after tax for FY25 despite an 8.7% revenue decline, driven by strong growth in Wholesale and Inbound segments and strategic investments in technology and acquisitions.

Beforepay Group Limited reported a strong FY25 with a 29% increase in net transaction margin and 14% revenue growth, driven by expanding user numbers and advances. The company continues to leverage AI-driven risk management while maintaining its ethical lending model.

Centrepoint Alliance has reported a robust FY25 financial performance, surpassing earnings guidance with a 16% rise in EBITDA and a 30% jump in pre-tax profits. The company also declared a 1.75 cent final dividend and advanced its technology and advisory services.

Coles Group Limited reported solid FY25 results with strong supermarket growth, digital acceleration, and significant sustainability achievements. The company’s investments in automation and customer experience underpin its positive outlook for FY26.

Coles Group delivered a robust FY25 performance with a 3.6% rise in group sales revenue and a strong 10.7% increase in underlying EBITDA, driven by its supermarkets division and digital expansion.

Coles Group Limited reported modest growth in FY25 with $44.35 billion revenue and $1.08 billion net profit, underpinned by major supply chain investments and sustainability milestones. The company maintained dividends but faces ongoing legal challenges.

Nanosonics delivered a robust FY25 with 17% revenue growth and a 72% jump in profit before tax, propelled by next-gen trophon devices and advancing CORIS commercialisation.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.